1. Background
2. Objectives
3. Methods
4. Results
4.1. Characteristics of Mother-Child Pairs and Sequencing Data
| Patients | Gender | Age, y | HBsAg | HBsAb | HBeAg | HBeAb | HBcAb | ALT, U/L | AST, U/L | HBV DNA, IU/mL | Dominant Genotype |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 1C | Male | 8 | + | - | + | - | + | 11.4 | 24.2 | 9.91 × 107 | B |
| 1M | Female | 35 | + | - | + | - | + | 31.0 | 30.0 | 1.19 × 108 | B |
| 2C | Female | 11 | + | - | + | - | + | 29.4 | 28.8 | 1.65 × 106 | B |
| 2M | Female | 36 | + | - | + | - | + | 23.0 | 24.0 | 3.81 × 107 | B |
| 3C | Male | 15 | + | - | + | - | + | 19.0 | 29.0 | 6.21 × 107 | B |
| 3M | Female | 40 | + | - | - | + | + | 7.0 | 25.0 | 2.62 × 108 | B |
| 4C | Male | 7 | + | - | + | - | + | 25.0 | 30.0 | 1.08 × 108 | B |
| 4M | Female | 40 | + | - | - | + | + | 16.0 | 19.0 | < 1.00 × 103 | B |
| 5C | Female | 1.5 | + | - | + | - | + | 38.0 | 42.7 | 1.49 × 106 | B |
| 5M | Female | 27 | + | - | + | - | + | 11.0 | 17.0 | 5.83 × 107 | B |
| 6C | Female | 3 | + | - | + | - | + | 20.0 | 40.0 | 4.14 × 107 | C |
| 6M | Female | 30 | + | - | + | - | + | 49.0 | 38.0 | 3.97 × 107 | C |
| 7C | Female | 0.8 | + | - | + | - | + | 23.3 | 32.3 | 2.34 × 107 | C |
| 7M | Female | 27 | + | - | + | - | + | 23.0 | 23.0 | 8.99 × 107 | C |
| 8C | Female | 4 | + | - | + | - | + | 42.0 | 44.0 | 3.83 × 107 | B |
| 8M | Female | 30 | + | - | + | - | + | 37.0 | 35.0 | 1.99 × 108 | B |
| 9C | Male | 7 | + | - | + | - | + | 44.0 | 44.0 | 1.16E + 07 | B |
| 9M | Female | 32 | + | - | + | - | + | 9.0 | 20.0 | 2.76E + 07 | B |
Abbreviations: ALT, alanine aminotransferase; AST, aspartate amino transferase; C, child; HBV, hepatitis B virus; HBsAg, hepatitis B surface antigen; HBsAb, hepatitis B surface antibody; HBcAb, antibody to hepatitis B core antigen; HBeAg, hepatitis B e antigen; M, mother.
4.2. High Conservative of HBV S Region in Vertical Transmission
4.3. The Influence of Mutations in HBsAg Region
| 102G | 107C | 108P | 109L | 110I | 112G | 113S | 117S | 119G | 120P | 123T | 124C | 126T | 133M | 137C | 139C | 140T | 141K | 142P | 143T | 145G | 160K | 161Y/F | 162L | 164E | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1M | S | L | I | L/V | R | T/G | G | I/N | S | I | R | R | R | C | |||||||||||
| 1C | S | L | I | L/V | R | T | G | S | I | R | R | R | C | ||||||||||||
| 2M | S | L | I | L/V | R | T | L | S | I | R | R | R | C | ||||||||||||
| 2C | S | L/H | I | L/V | R | T | R | Q/R/L | S | I | R | R | R | C | V | G | |||||||||
| 3M | D | S | L | I | L/V | R | T | G | R | Q/R | I/N | G/S | S | I | R | R | R | C | |||||||
| 3C | S | L | I | L/V | R | T | G | I/N | S | I | R | L | R | R | C | V | |||||||||
| 4M | D | S | L | I | L/V | R | T | G | I/N | S | I | R | R | R | C | ||||||||||
| 4C | S | L | I | L/V | R | T | G | R | I/N | I | S | I | R | S | R | R/I | C | ||||||||
| 5M | S | L | L/V | R | T | I/N | S | I | R | R | R | C | V | ||||||||||||
| 5C | S | L | I | L/V | R | T | G | S | I | R | R | R | C | ||||||||||||
| 6M | D | L | I | R | R | Q/R | Y | R | L | V | |||||||||||||||
| 6C | D | S | L | I | R | R | Q/R | I | Y | R | L | C | V | ||||||||||||
| 7M | D | L | I | R | G | R | Q/R | Y | R | L | V | ||||||||||||||
| 7C | D | S | L | I | R | G | R | Q/R | S | Y | R | L | R | C | V | ||||||||||
| 8M | S | L | I | L/V | R | T | G | Y | R | L | R | C | V | ||||||||||||
| 8C | S | L | I | L/V | R | T | G | Y | R | L | R | V | |||||||||||||
| 9M | S | L | I | L/V | R | T | G | S | I | R | R | R | C | ||||||||||||
| 9C | S | L | I | L/V | R | T | S | R | C |
Abbreviations: C, child; M, mother.
4.4. Secondary Structure Analysis of HBV Surface Protein
Predicted transmembrane domains of HBsAg and confidence of disulfide bonding state prediction. A, The predicted transmembrane domains of HBsAg for WT, C137S and C139Y; WT, wild type. B, confidence of disulfide bonding state prediction of “a” determinant for WT, C137S and C139Y; the mutations were in red frame. C, Model of the “a” determinant in HBsAg, circles represent amino acids and solid lines were of disulfide bonds. D, model of the “a” determinant in HBsAg with mutations, circles represent amino acids and solid lines were of disulfide bonds, red lines represent that the disulfide bonds were broken.


